Inventor
MCWHIRTER JOHN
US82 patents
⚠️ This page may combine multiple inventors who share the name “MCWHIRTER JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
33 patentsUS10412940B2Sep 17, 2019
Mice expressing a limited immunoglobulin light chain repertoire
REGENERON PHARMA38 citations98
US9113616B2Aug 25, 2015
Genetically modified mice having humanized TCR variable genes
REGENERON PHARMA67 citations97
US9796788B2Oct 24, 2017
Mice expressing a limited immunoglobulin light chain repertoire
REGENERON PHARMA26 citations94
US9334334B2May 10, 2016
Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same
REGENERON PHARMA31 citations94
US9301510B2Apr 5, 2016
Mice that produce antigen-binding proteins with pH-dependent binding characteristics
REGENERON PHARMA28 citations94
US9204624B2Dec 8, 2015
Non-human animals with modifed immunoglobulin heavy chain sequences
REGENERON PHARMA30 citations94
US9332742B2May 10, 2016
Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same
REGENERON PHARMA19 citations93
US9795121B2Oct 24, 2017
Humanized C3 animals
REGENERON PHARMA18 citations92
US9738897B2Aug 22, 2017
Nuclease-mediated DNA assembly
REGENERON PHARMA13 citations91
US11559050B2Jan 24, 2023
Humanized non-human animals with restricted immunoglobulin heavy chain loci
REGENERON PHARMA4 citations86
US9969814B2May 15, 2018
Methods for making fully human bispecific antibodies using a common light chain
REGENERON PHARMA18 citations86
US10246509B2Apr 2, 2019
Restricted immunoglobulin heavy chain mice
REGENERON PHARMA6 citations84
US10238093B2Mar 26, 2019
Humanized non-human animals with restricted immunoglobulin heavy chain loci
REGENERON PHARMA12 citations84
US10167344B2Jan 1, 2019
Mice expressing a limited immunoglobulin light chain repertoire
REGENERON PHARMA7 citations84
US9930871B2Apr 3, 2018
Non-human animals with modified immunoglobulin heavy chain sequences
REGENERON PHARMA7 citations84
US9801362B2Oct 31, 2017
Non-human animals expressing pH-sensitive immunoglobulin sequences
REGENERON PHARMA9 citations84
US9730435B2Aug 15, 2017
Non-human animals having a humanized a proliferation-inducing ligand gene
REGENERON PHARMA5 citations84
US9648856B2May 16, 2017
Non-human animals expressing pH-sensitive immunoglobulin sequences
REGENERON PHARMA9 citations84
US9629347B2Apr 25, 2017
Non-human animals having a humanized B-cell activating factor gene
REGENERON PHARMA6 citations84
US9615550B2Apr 11, 2017
Genetically modified major histocompatibility complex mice
REGENERON PHARMA12 citations84
US9591835B2Mar 14, 2017
Genetically modified major histocompatibility complex animals
REGENERON PHARMA11 citations84
US9963501B2May 8, 2018
B cell lineage based immunogen design with humanized animals
REGENERON PHARMA6 citations82
US9580715B2Feb 28, 2017
Nuclease-mediated DNA assembly
REGENERON PHARMA7 citations82
US12389888B2Aug 19, 2025
Mice expressing a limited immunoglobulin light chain repertoire
REGENERON PHARMA1 citations75
US11666040B2Jun 6, 2023
Humanized non-human animals with restricted immunoglobulin heavy chain loci
REGENERON PHARMA3 citations73
US11528895B2Dec 20, 2022
Genetically modified T cell receptor mice
REGENERON PHARMA2 citations73
US11261248B2Mar 1, 2022
Restricted immunoglobulin heavy chain mice
REGENERON PHARMA2 citations73
US11026407B2Jun 8, 2021
Mice expressing a limited immunoglobulin light chain repertoire
REGENERON PHARMA2 citations73
US11000020B2May 11, 2021
Non-human animals having a humanized B-cell activating factor gene
REGENERON PHARMA1 citations73
US10869466B2Dec 22, 2020
Genetically modified major histocompatibility complex mice
REGENERON PHARMA2 citations73
US10219494B2Mar 5, 2019
Non-human animals having a humanized B-cell activating factor gene
REGENERON PHARMA2 citations73
US11051498B2Jul 6, 2021
Mouse having an engineered immunoglobulin lambda light chain
REGENERON PHARMA2 citations72
US10820582B2Nov 3, 2020
Non-human animals having an engineered immunoglobulin Λ light chain locus
REGENERON PHARMA3 citations71
ALEXION PHARMA INC
6 patentsUS7435412B2Oct 14, 2008
Chronic lymphocytic leukemia cell line
ALEXION PHARMA INC34 citations96
US7408041B2Aug 5, 2008
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
ALEXION PHARMA INC39 citations96
US7427665B2Sep 23, 2008
Chronic lymphocytic leukemia cell line
ALEXION PHARMA INC20 citations92
US7714110B2May 11, 2010
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
ALEXION PHARMA INC8 citations84
US7598353B2Oct 6, 2009
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
ALEXION PHARMA INC10 citations84
USRE41365EJun 1, 2010
Nested oligonucleotides containing a hairpin for nucleic acid amplification
ALEXION PHARMA INC15 citations83
BOWDISH KATHERINE S
5 patentsUS8840885B2Sep 23, 2014
Methods for treating chronic lymphocytic leukemia
BOWDISH KATHERINE S12 citations92
US8114403B2Feb 14, 2012
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
BOWDISH KATHERINE S23 citations92
US8187877B2May 29, 2012
Chronic lymphocytic leukemia cell line
BOWDISH KATHERINE S7 citations84
US9150661B2Oct 6, 2015
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
BOWDISH KATHERINE S7 citations83
US9249229B2Feb 2, 2016
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
BOWDISH KATHERINE S6 citations73
MCWHIRTER JOHN
2 patentsLENSAR INC
2 patentsREGENERAN PHARMACEUTICALS INC
1 patentCURATU GEORGE C
1 patentShowing the top 50 of 82 patents by PatentIndex Score.